Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
Christoph Boss,Christine Brotschi,Markus Gude,Bibia Heidmann,Thierry Sifferlen,Markus Von Raumer,Jodi T. Williams
申请号：
US15101832
公开号：
US09790208B2
申请日:
2014.12.02
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to a crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride, processes for the preparation thereof, pharmaceutical compositions containing said crystalline form, and its use as medicament, especially as orexin receptor antagonist.
